| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |